The Limb Salvage Center

Filter Your Results




FDA Approves Phase 1 Trial of Alucent Medical's Natural Vascular Scaffold Therapy

May 16, 2017 -- Alucent Medical, Inc. announced that it has received US Food and Drug Administration (FDA) approval to begin phase 1 human clinical studies of the company'…

QT Vascular and Medtronic Enter Into Asset Purchase Option Agreement for the Chocolate PTA Catheter

May 12, 2017 -- QT Vascular Ltd. announced that it has entered into an asset purchase option agreement with Medtronic for the acquisition of QT Vascular's non -- drug-coat…

DANCE Trial Investigates Dexamethasone Infusion to Enhance Femoropopliteal Revascularization

May 11, 2017 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced that Ehrin J. Armstrong, MD, presented results from an analysis of inflammat…

Ask the Experts: How Can Current Endpoints in Below-the-Knee Clinical Trials Be Improved?

With Thomas Zeller, MD; Mahmood K. Razavi, MD, FSIR, FSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Marianne Brodmann, MD

May 2017—Experts discuss how to better align trial endpoints for improved assessment of below-the-knee outcomes in patients with critical limb ischemia.

Ultrasound Techniques to Enhance Our Understanding of Below-the-Knee Outcomes

Francesco Liistro, MD

May 2017—Tips for using extravascular ultrasound guidance to evaluate below-the-knee disease and select the proper tools for treatment.

Cone-Beam CT and Advanced Perfusion in CLI Interventions

Andrew Holden, MBChB, FRANZCR, EBIR

May 2017—Objectively measuring tissue perfusion at the site of tissue loss using two- and three-dimensional techniques.

CT Reconstruction in Critical Limb Ischemia Planning

Biraj B. Bista, MD, and John Moriarty, MD

May 2017—An overview of the available CT reconstruction techniques to plan CLI treatment.

Utility of Noncontrast-Enhanced MRA in Patients With Critical Limb Ischemia

Jos C. van den Berg, MD, PhD

May 2017—A review of classic and new techniques for diagnosis and procedural planning, with a focus on the quiescent-interval single-shot technique.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.